Adalimumab - ADD-ah-lim-u-mab is using to decreased signs, symptoms and progression of moderately to severely active rheumatoid arthritis. It is intended for use in diseaseds who have not responded well to other Disease Modifying Antirheumatic Drugs - DMARDS. Adalimumab can be using in combination with methotrexate or other DMARD's.
This drug is available only with your family doctor's prescription, in the following dosage forms:
Some commonly using brand names are:
In the USA
Generic name product may be available in the USA
† Not commercially available in Canada.